The dichotomous pattern of IL-12R and IL-23R expression elucidates the role of IL-12 and IL-23 in inflammation

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Chognard, Gaëlle ^a,b   Bellemare, Lisa ^a,b   Pelletier, Adam Nicolas ^a,b   Dominguez Punaro, Maria C ^a   Beauchamp, Claudine ^c   Guyon, Marie Josée ^a   Charron, Guy ^c   Morin, Nicolas ^c   Sivanesan, Durga ^b   Kuchroo, Vijay ^d   Xavier, Ramnik ^e   Michnick, Stephen W ^b   Chemtob, Sylvain ^f   Rioux, John D ^b,c   Lesage, Sylvie ^a,b  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MONTREAL HEART INSTITUTE   (Canada)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HARVARD UNIVERSITY   (United States)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; COMPLEMENTARY DNA; CYTOKINE; IL12RB2 PROTEIN, HUMAN; INTERLEUKIN RECEPTOR; INTERLEUKIN-23 RECEPTOR, MOUSE; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CELL INTERACTION; CELL LINEAGE; CHRONIC DISEASE; COLITIS; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY DISEASE; LYMPHOID CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; ANIMAL; BIOLOGICAL MODEL; BLOOD; FLOW CYTOMETRY; GENETICS; HELPER CELL; HISTOLOGY; IMMUNOLOGY; METABOLISM; NONPARAMETRIC TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CYTOKINES; DNA PRIMERS; DNA, COMPLEMENTARY; FLOW CYTOMETRY; HISTOLOGICAL TECHNIQUES; HUMANS; INFLAMMATION; INTERLEUKIN-12; INTERLEUKIN-23; KILLER CELLS, NATURAL; MICE; MODELS, IMMUNOLOGICAL; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84896759216     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089092     Document Type: Article

References (59)

1. Parham C, Chirica M, Timans J, Vaisberg E, Travis M, et al. (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168: 5699-5708. (Pubitemid 34556153)
2. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, et al. (1996) A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A 93: 14002-14007.
3. Casanova JL, Abel L (2004) The human model: a genetic dissection of immunity to infection in natural conditions. Nat Rev Immunol 4: 55-66.
4. Torti DC, Feldman SR (2007) Interleukin-12, interleukin-23, and psoriasis: current prospects. J Am Acad Dermatol 57: 1059-1068.
5. Benson JM, Sachs CW, Treacy G, Zhou H, Pendley CE, et al. (2011) Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab. Nat Biotechnol 29: 615-624.
6. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, et al. (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463. (Pubitemid 44871953)
7. Wong RH, Wei JC, Huang CH, Lee HS, Chiou SY, et al. (2012) Association of IL-12B genetic polymorphism with the susceptibility and disease severity of ankylosing spondylitis. J Rheumatol 39: 135-140.
8. Filer C, Ho P, Smith RL, Griffiths C, Young HS, et al. (2008) Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum 58: 3705-3709.
9. Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, et al. (2009) Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 360: 2544-2555.
10. Rivas MA, Beaudoin M, Gardet A, Stevens C, Sharma Y, et al. (2011) Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 43: 1066-1073.
11. Momozawa Y, Mni M, Nakamura K, Coppieters W, Almer S, et al. (2011) Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet 43: 43-47.
12. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, et al. (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80: 273-290. (Pubitemid 46175676)
13. Liu Y, Helms C, Liao W, Zaba LC, Duan S, et al. (2008) A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 4: e1000041.
14. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40: 955-962.
15. Mells GF, Floyd JA, Morley KI, Cordell HJ, Franklin CS, et al. (2011) Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet 43: 329-332.
16. Awasthi A, Riol-Blanco L, Jager A, Korn T, Pot C, et al. (2009) Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J Immunol 182: 5904-5908.
17. Uhlig HH, McKenzie BS, Hue S, Thompson C, Joyce-Shaikh B, et al. (2006) Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25: 309-318.
18. Trinchieri G, Wysocka M, D'Andrea A, Rengaraju M, Aste-Amezaga M, et al. (1992) Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog Growth Factor Res 4: 355-368.
19. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, et al. (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170: 827-845. (Pubitemid 19226667)
20. Ribot JC, deBarros A, Pang DJ, Neves JF, Peperzak V, et al. (2009) CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets. Nat Immunol 10: 427-436.
21. Yosef N, Shalek AK, Gaublomme JT, Jin H, Lee Y, et al. (2013) Dynamic regulatory network controlling TH17 cell differentiation. Nature 496: 461-468.
22. Riol-Blanco L, Lazarevic V, Awasthi A, Mitsdoerffer M, Wilson BS, et al. (2010) IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections. J Immunol 184: 1710-1720.
23. Rachitskaya AV, Hansen AM, Horai R, Li Z, Villasmil R, et al. (2008) Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol 180: 5167-5171.
24. Cocco C, Morandi F, Airoldi I (2011) Interleukin-27 and interleukin-23 modulate human plasmacell functions. J Leukoc Biol 89: 729-734.
25. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, et al. (2013) Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 13: 145-149.
26. Belladonna ML, Renauld JC, Bianchi R, Vacca C, Fallarino F, et al. (2002) IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells. J Immunol 168: 5448-5454. (Pubitemid 34556122)
27. Kastelein RA, Hunter CA, Cua DJ (2007) Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 25: 221-242. (Pubitemid 46697908)
28. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC (2006) A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 203: 1685-1691. (Pubitemid 44036274)
29. Novick D, Kim S, Kaplanski G, Dinarello CA (2013) Interleukin-18, more than a Th1 cytokine. Semin Immunol.
30. Takeuchi M, Nishizaki Y, Sano O, Ohta T, Ikeda M, et al. (1997) Immunohistochemical and immuno-electron-microscopic detection of interfer-on-gamma-inducing factor ("interleukin-18") in mouse intestinal epithelial cells. Cell Tissue Res 289: 499-503. (Pubitemid 27367886)
31. Puren AJ, Fantuzzi G, Dinarello CA (1999) Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human bloodmononuclear cells andmouse spleen cells. Proc Natl Acad Sci U S A 96: 2256-2261. (Pubitemid 29117901)
32. Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3: 133-146.
33. Hunter CA (2005) New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5: 521-531.
34. Cooper AM, Khader SA (2007) IL-12p40: an inherently agonistic cytokine. Trends Immunol 28: 33-38. (Pubitemid 44960157)
35. Chakir H, Camilucci AA, Filion LG, Webb JR (2000) Differentiation of murine NK cells into distinct subsets based on variable expression of the IL-12R beta 2 subunit. J Immunol 165: 4985-4993.
36. Ludviksson BR, Ehrhardt RO, Strober W (1999) Role of IL-12 in intrathymic negative selection. J Immunol 163: 4349-4359. (Pubitemid 29474502)
37. Smeltz RB, Chen J, Ehrhardt R, Shevach EM (2002) Role of IFN-gamma in Th1 differentiation: IFN-gamma regulates IL-18R alpha expression by preventing the negative effects of IL-4 and by inducing/maintaining IL-12 receptor beta 2 expression. J Immunol 168: 6165-6172. (Pubitemid 34620035)
38. Eberl G, Marmon S, Sunshine MJ, Rennert PD, Choi Y, et al. (2004) An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 5: 64-73. (Pubitemid 38081470)
39. Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, et al. (2009) Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 206: 35-41.
40. Eisenring M, vom Berg J, Kristiansen G, Saller E, Becher B (2010) IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46. Nat Immunol 11: 1030-1038.
41. Satoh-Takayama N, Dumoutier L, Lesjean-Pottier S, Ribeiro VS, Mandelboim O, et al. (2009) The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. J Immunol 183: 6579-6587.
42. Hoeman CM, Dhakal M, Zaghouani AA, Cascio JA, Wan X, et al. (2013) Developmental expression of IL-12Rbeta2 on murine naive neonatal T cells counters the upregulation of IL-13Ralpha1 on primary Th1 cells and balances immunity in the newborn. J Immunol 190: 6155-6163.
43. Lexberg MH, Taubner A, Forster A, Albrecht I, Richter A, et al. (2008) Th memory for interleukin-17 expression is stable in vivo. Eur J Immunol 38: 2654-2664.
44. Liao W, Lin JX, Wang L, Li P, Leonard WJ (2011) Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat Immunol 12: 551-559.
45. Kano S, Sato K, Morishita Y, Vollstedt S, Kim S, et al. (2008) The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells. Nat Immunol 9: 34-41. (Pubitemid 350286201)
46. Tokumasa N, Suto A, Kagami S, Furuta S, Hirose K, et al. (2007) Expression of Tyk2 in dendritic cells is required for IL-12, IL-23, and IFN-gamma production and the induction of Th1 cell differentiation. Blood 110: 553-560. (Pubitemid 47105393)
47. Cox JH, Kljavin NM, Ota N, Leonard J, Roose-Girma M, et al. (2012) Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice. Mucosal Immunol 5: 99-109.
48. Buonocore S, Ahern PP, Uhlig HH, Ivanov, II, Littman DR, et al. (2010) Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature.
49. Hue S, Ahern P, Buonocore S, Kullberg MC, Cua DJ, et al. (2006) Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 203: 2473-2483. (Pubitemid 44664617)
50. Eken A, Singh AK, Treuting PM, Oukka M (2013) IL-23R innate lymphoid cells induce colitis via interleukin-22-dependent mechanism. Mucosal Immunol.
51. Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hutnick NA, et al. (2012) Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336: 1321-1325.
52. Yamazaki K, Onouchi Y, Takazoe M, Kubo M, Nakamura Y, et al. (2007) Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients. J Hum Genet 52: 575-583. (Pubitemid 47012531)
53. Cummings JR, Ahmad T, Geremia A, Beckly J, Cooney R, et al. (2007) Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype. Inflamm Bowel Dis 13: 1063-1068. (Pubitemid 47402588)
54. Tremelling M, Cummings F, Fisher SA, Mansfield J, Gwilliam R, et al. (2007) IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology 132: 1657-1664. (Pubitemid 46695721)
55. Kim SW, Kim ES, Moon CM, Park JJ, Kim TI, et al. (2011) Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease. Gut 60: 1527-1536.
56. Sarin R, Wu X, Abraham C (2011) Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Proc Natl Acad Sci U S A 108: 9560-9565.
57. Basu R, O'Quinn DB, Silberger DJ, Schoeb TR, Fouser L, et al. (2012) Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 37: 1061-1075.
58. Airoldi I, Di Carlo E, Cocco C, Sorrentino C, Fais F, et al. (2005) Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. Blood 106: 3846-3853. (Pubitemid 41739022)
59. Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol.